Serplulimab in Podcasts
productSerplulimab is a PD-1 checkpoint inhibitor developed by Fosun Pharma, used in lung cancer.
Mentions Over Time
1
mentions
1
related entities
Related Entities
Mentions in Podcasts
Vanguards of Health Care by Bloomberg Intelligence
Fosun Pharma’s Drive Beyond China
One of my favorite in the Henleus Fosun Pharma world is Serplulimab.